Logo image of ALBIZ.PA

OBIZ SA (ALBIZ.PA) Stock Fundamental Analysis

EPA:ALBIZ - FR0014003711 - Common Stock

3.59 EUR
+0.07 (+1.99%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

Overall ALBIZ gets a fundamental rating of 3 out of 10. We evaluated ALBIZ against 62 industry peers in the Media industry. While ALBIZ seems to be doing ok healthwise, there are quite some concerns on its profitability. ALBIZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALBIZ has reported negative net income.
ALBIZ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALBIZ reported negative net income in multiple years.
ALBIZ had a positive operating cash flow in 4 of the past 5 years.
ALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFALBIZ.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 1M -1M 2M -2M

1.2 Ratios

With a Return On Assets value of -4.69%, ALBIZ is not doing good in the industry: 70.97% of the companies in the same industry are doing better.
ALBIZ has a worse Return On Equity (-21.64%) than 70.97% of its industry peers.
Industry RankSector Rank
ROA -4.69%
ROE -21.64%
ROIC N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ALBIZ.PA Yearly ROA, ROE, ROICALBIZ.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Gross Margin of ALBIZ (13.37%) is worse than 85.48% of its industry peers.
ALBIZ's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALBIZ so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
ALBIZ.PA Yearly Profit, Operating, Gross MarginsALBIZ.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

ALBIZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALBIZ has more shares outstanding
The number of shares outstanding for ALBIZ has been increased compared to 5 years ago.
ALBIZ has a better debt/assets ratio than last year.
ALBIZ.PA Yearly Shares OutstandingALBIZ.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
ALBIZ.PA Yearly Total Debt VS Total AssetsALBIZ.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.79 indicates that ALBIZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.79, ALBIZ belongs to the top of the industry, outperforming 90.32% of the companies in the same industry.
A Debt/Equity ratio of 1.70 is on the high side and indicates that ALBIZ has dependencies on debt financing.
The Debt to Equity ratio of ALBIZ (1.70) is worse than 75.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Altman-Z 2.79
ROIC/WACCN/A
WACC5.87%
ALBIZ.PA Yearly LT Debt VS Equity VS FCFALBIZ.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

ALBIZ has a Current Ratio of 2.17. This indicates that ALBIZ is financially healthy and has no problem in meeting its short term obligations.
ALBIZ has a Current ratio of 2.17. This is amongst the best in the industry. ALBIZ outperforms 95.16% of its industry peers.
ALBIZ has a Quick Ratio of 1.90. This is a normal value and indicates that ALBIZ is financially healthy and should not expect problems in meeting its short term obligations.
ALBIZ has a better Quick ratio (1.90) than 93.55% of its industry peers.
Industry RankSector Rank
Current Ratio 2.17
Quick Ratio 1.9
ALBIZ.PA Yearly Current Assets VS Current LiabilitesALBIZ.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

5

3. Growth

3.1 Past

The earnings per share for ALBIZ have decreased strongly by -2780.72% in the last year.
Looking at the last year, ALBIZ shows a very strong growth in Revenue. The Revenue has grown by 51.46%.
Measured over the past years, ALBIZ shows a very strong growth in Revenue. The Revenue has been growing by 67.67% on average per year.
EPS 1Y (TTM)-2780.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2710.29%
Revenue 1Y (TTM)51.46%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%5.73%

3.2 Future

ALBIZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 173.24% yearly.
ALBIZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.63% yearly.
EPS Next Y366.68%
EPS Next 2Y230.65%
EPS Next 3Y173.24%
EPS Next 5YN/A
Revenue Next Year6.86%
Revenue Next 2Y6.6%
Revenue Next 3Y8.87%
Revenue Next 5Y6.63%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALBIZ.PA Yearly Revenue VS EstimatesALBIZ.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
ALBIZ.PA Yearly EPS VS EstimatesALBIZ.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

2

4. Valuation

4.1 Price/Earnings Ratio

ALBIZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 29.87, ALBIZ can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALBIZ indicates a slightly more expensive valuation: ALBIZ is more expensive than 61.29% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.69, ALBIZ is valued a bit more expensive.
Industry RankSector Rank
PE N/A
Fwd PE 29.87
ALBIZ.PA Price Earnings VS Forward Price EarningsALBIZ.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALBIZ is valued a bit more expensive than the industry average as 69.35% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.7
ALBIZ.PA Per share dataALBIZ.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALBIZ's earnings are expected to grow with 173.24% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y230.65%
EPS Next 3Y173.24%

0

5. Dividend

5.1 Amount

No dividends for ALBIZ!.
Industry RankSector Rank
Dividend Yield N/A

OBIZ SA

EPA:ALBIZ (9/5/2025, 7:00:00 PM)

3.59

+0.07 (+1.99%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners53.65%
Ins Owner ChangeN/A
Market Cap21.07M
Analysts87.27
Price Target8.3 (131.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-54.25%
EPS NY rev (3m)-54.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 29.87
P/S 0.17
P/FCF N/A
P/OCF 20.19
P/B 1.76
P/tB N/A
EV/EBITDA 16.7
EPS(TTM)-0.44
EYN/A
EPS(NY)0.12
Fwd EY3.35%
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)0.18
OCFY4.95%
SpS21.44
BVpS2.04
TBVpS-2.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.69%
ROE -21.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.37%
FCFM N/A
ROA(3y)-1.35%
ROA(5y)-1.29%
ROE(3y)-6.63%
ROE(5y)-2.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.72%
GM growth 5Y-18.3%
F-Score4
Asset Turnover2.28
Health
Industry RankSector Rank
Debt/Equity 1.7
Debt/FCF N/A
Debt/EBITDA 9.61
Cap/Depr 119.21%
Cap/Sales 2.2%
Interest Coverage N/A
Cash Conversion 49.18%
Profit Quality N/A
Current Ratio 2.17
Quick Ratio 1.9
Altman-Z 2.79
F-Score4
WACC5.87%
ROIC/WACCN/A
Cap/Depr(3y)85.83%
Cap/Depr(5y)92.26%
Cap/Sales(3y)2.18%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2780.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2710.29%
EPS Next Y366.68%
EPS Next 2Y230.65%
EPS Next 3Y173.24%
EPS Next 5YN/A
Revenue 1Y (TTM)51.46%
Revenue growth 3Y50.48%
Revenue growth 5Y67.67%
Sales Q2Q%5.73%
Revenue Next Year6.86%
Revenue Next 2Y6.6%
Revenue Next 3Y8.87%
Revenue Next 5Y6.63%
EBIT growth 1Y-120.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year209.24%
EBIT Next 3Y91.94%
EBIT Next 5Y57.12%
FCF growth 1Y-434.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.6%
OCF growth 3YN/A
OCF growth 5Y4.44%